Key facts
- It has raised $106.3M; the latest was Debt - General ($30.0M) in Jan 2025.
- Notable investors include Wisconsin Economic Development, WARF Ventures, Baird Capital, RC Capital (Cincinnati), Avestria Ventures — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Elucent Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Elucent Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Elucent Medical
Developer of a breast cancer detection system designed to eliminate the need for a metal clip. The company's detection system shows tumor margins during surgical excision, as well as simplifies breast cancer treatment by making procedures accessible and affordable, enabling surgeons to preserve their patient's breasts as much as possible while removing cancer.
- Sector
- Healthcare
- HQ
- Eden Prairie, MN, United States
- Founded
- 2013
- Employees
- 118
- Website
- elucent.com/
- Ownership
- Privately Held (backing)
Elucent Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Elucent Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Elucent Medical in its N-PORT filings yet. We sweep new filings monthly.